Global Myeloma Voices for Research and Patient Care

Global Myeloma Voices Come Together to Drive Research and Improve the Lives of Patients

In his blog this week, IMF Chairman Dr. Brian Durie reports from Madrid on the exciting way global myeloma voices are “increasingly coming together with a single voice for myeloma research and patient care.” Three IMF events held on the eve of the European Hematology Association annual congress provided the settings for these voices: the IMF’s Black Swan Research Initiative® investigators meeting, the 2017 International Myeloma Working Group® (IMWG) Summit, and the Global Myeloma Action Network® Summit. Read Dr. Durie’s blog.

Save the Date: Myeloma Updates 2017: Best of ASCO/EHA/IMWG Webinar - July 13th, 2017 

On Thursday, July 13th, 2017 at 4:00 PM PT / 7:00 PM ET, Dr. Brian Durie will explain the new and exciting current trends in myeloma treatment and research during a Myeloma Updates 2017 webinar. This webinar will feature updates from the three major medical meetings held in June 2017 – the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA), and the International Myeloma Working Group Summit (IMWG). Register for FREE now for this webinar that includes a Q&A session

 

Watch This Video on Ideal Imaging Tests for Myeloma in 2017

During the International Myeloma Working Group annual meeting in Madrid, Spain last week, leading myeloma experts discussed six topline questions in the field of myeloma. Here is the first question from that meeting: What is ideal imaging in 2017? View more IMWG videos

 

Learn about the Impact of BMI on Early Progression of Smoldering Multiple Myeloma

In this video, Dr. Wilson I. Gonsalves from the Mayo Clinic in Rochester, Minnesota, discusses the impact of body mass index (BMI) on the risk of early progression of smoldering multiple myeloma to symptomatic myeloma. View this and other topline videos from ASCO 2017.

Calling All Researchers: Submit Your Grant Applications!

The Brian D. Novis Research Grants honor the IMF’s founder Brian Novis, who died of multiple myeloma in July of 1992. The grants are awarded to researchers in the field of multiple myeloma and related disorders including SMM (smoldering multiple myeloma), MGUS (monoclonal gammopathy of undetermined significance), and immunoglobulin-derived amyloidosis. The 2018 grants will fund senior research projects with $80,000 and junior research projects with $50,000. Tuesday, August1st, 2017, is the deadline for applications.

 

Is MGUS always asymptomatic?

In this video, Dr. Brian Durie explains that even though MGUS is benign, some MGUS patients may develop symptoms due to the presence of abnormal monoclonal protein in the blood.

 

 


We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Pharmaceuticals, and Takeda Oncology